Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Regulation

Mifepristone

Republicans Push to Restore In‑Person Rules for Abortion Pill at Fiery Senate Hearing

HHS says its safety review continues days after a JAMA analysis reaffirmed the FDA’s long‑standing findings on mifepristone.

Senate Democrats Press FDA on Mifepristone Review After Court Strikes Down Restrictions

GOP Senators Move to Curb Mifepristone After FDA Clears Second Generic